The genomic landscape and treatment outcomes associated with CDKN2A/MTAP loss in patients with non-small cell lung cancer.

Vokes NI, Symons JL, Rhead B, Hong L, Shah PA, Lai Z, Zhu Z, Treviño S, Bryan J, Wu J, Zhang J, Gibbons D, Heymach JV, Stewart R, Iyer S, Leventakos K, Fragkogianni S, Chao C, Rodon JA

Open source

DOI: 10.1158/1078-0432.ccr-26-0771
Published: 2026 Jul 27
Container: Clinical cancer research : an official journal of the American Association for Cancer Research
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1158/1078-0432.ccr-26-0771,
  title = {The genomic landscape and treatment outcomes associated with CDKN2A/MTAP loss in patients with non-small cell lung cancer.},
  author = {Vokes NI and Symons JL and Rhead B and Hong L and Shah PA and Lai Z and Zhu Z and Treviño S and Bryan J and Wu J and Zhang J and Gibbons D and Heymach JV and Stewart R and Iyer S and Leventakos K and Fragkogianni S and Chao C and Rodon JA},
  year = {2026},
  journal = {Clinical cancer research : an official journal of the American Association for Cancer Research},
  doi = {10.1158/1078-0432.ccr-26-0771},
  url = {https://doi.org/10.1158/1078-0432.ccr-26-0771}
}

RIS

TY  - JOUR
TI  - The genomic landscape and treatment outcomes associated with CDKN2A/MTAP loss in patients with non-small cell lung cancer.
AU  - Vokes NI
AU  - Symons JL
AU  - Rhead B
AU  - Hong L
AU  - Shah PA
AU  - Lai Z
AU  - Zhu Z
AU  - Treviño S
AU  - Bryan J
AU  - Wu J
AU  - Zhang J
AU  - Gibbons D
AU  - Heymach JV
AU  - Stewart R
AU  - Iyer S
AU  - Leventakos K
AU  - Fragkogianni S
AU  - Chao C
AU  - Rodon JA
PY  - 2026
JO  - Clinical cancer research : an official journal of the American Association for Cancer Research
DO  - 10.1158/1078-0432.ccr-26-0771
UR  - https://doi.org/10.1158/1078-0432.ccr-26-0771
ER  -

APA

NI, V., JL, S., B, R., L, H., PA, S., Z, L., Z, Z., S, T., J, B., J, W., J, Z., D, G., JV, H., R, S., S, I., K, L., S, F., C, C., & JA, R. (2026). The genomic landscape and treatment outcomes associated with CDKN2A/MTAP loss in patients with non-small cell lung cancer.. Clinical cancer research : an official journal of the American Association for Cancer Research. https://doi.org/10.1158/1078-0432.ccr-26-0771

Source records

pubmed · retrieved 2026-09-26T07:25:15.755Z